BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Federal Trade Commission
Chubb
Harvard Business School
Cantor Fitzgerald
Fish and Richardson
Healthtrust
Teva
Deloitte
Baxter

Generated: January 24, 2018

DrugPatentWatch Database Preview

MESNA Drug Profile

« Back to Dashboard

Drug patent expirations by year for MESNA
Pharmacology for MESNA
Medical Subject Heading (MeSH) Categories for MESNA

US Patents and Regulatory Information for MESNA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa MESNA mesna INJECTABLE;INTRAVENOUS 075811-001 Apr 26, 2001 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sagent Pharms MESNA mesna INJECTABLE;INTRAVENOUS 090913-001 Apr 13, 2010 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Institutional MESNA mesna INJECTABLE;INTRAVENOUS 076488-001 Mar 8, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan Labs Ltd MESNA mesna INJECTABLE;INTRAVENOUS 203364-001 Jul 18, 2014 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int MESNA mesna INJECTABLE;INTRAVENOUS 075739-001 Jan 9, 2004 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms Usa MESNA mesna INJECTABLE;INTRAVENOUS 075764-001 Apr 27, 2001 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Cipla
Harvard Business School
Boehringer Ingelheim
Accenture
Merck
Fuji
Covington
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot